TSC-101

Treatment Description

TSC-101 is a T cell therapy made from genetically engineered donor T cells. This therapy is being studied for use in patients who have recently had a haploidentical stem cell transplant.

Participating Centers

There are 11 centers running trials with this treatment. Enter a location below to find the closest center.